LEGAL STATUS — verified 1 Nov 2026: No temporary Schedule I order for concentrated 7-OH has been published. DEA's 14 Oct 2026 notice of intent would allow an order on or after 13 Nov 2026. MGPI, MGM-15, and MGM-16 remain in Schedule I under the 26 Aug 2026 temporary order. Recheck the Federal Register before counseling. Educational resource, not individualized medical advice.

Physician-led · Evidence-graded · Dual entry

Concentrated 7-OH needs a treatment bridge.

Scheduling may reduce future harm. People who are already dependent need a clear route into care—not a cliff edge. Choose the door that fits you.

Patients & families Recognize withdrawal, know when to seek urgent help, and find a route to care—without a self-detox recipe.
Clinicians Screen exposure, triage risk, and use a structured opioid-withdrawal treatment frame grounded in current evidence limits.

Start here

More ways in

Crisis & urgent signs Breathing trouble, collapse, or severe withdrawal—what to do now. Withdrawal course Provisional timeline, COWS limits, and what “feels like.” Treatment framework Buprenorphine pathways, methadone, naltrexone cautions. Clinical assessment Printable exposure and disposition template. Chemistry & testing What a drug test can—and cannot—establish. Metabolite & PK atlas Full compound glossary and pharmacokinetic tables. Pharmacology MOR dominance, bias limits, receptor catalogue. Special populations Pregnancy, frailty, cardiac risk, drug interactions. Legal tracker Dated federal and selected state status. Evidence library Graded sources behind the claims on this site. Downloads Protocols, appendices, CSV, primary PDFs. Full resource Continuous longform modules 01–12. About & contact How to reach Dr. Harris — care, colleagues, and press.

Contact

How to reach us

Brian Harris, MD · Addiction Medicine, Anesthesiology, and Sleep Medicine. Choose the path that matches your request.

Patients & families

For evaluation or care coordination related to substance-use disorders, including concentrated 7-OH, contact the practice office. Scheduling and intake are handled through eusomniamd.com.

(650) 308-4845 · office@eusomniamd.com

Clinicians

For clinical framing on concentrated 7-OH—screening, triage, and treatment pathways—start with the clinician door on this site. For case-specific collegial discussion after you have reviewed that material, write to bharris@eusomniamd.com.

Press, corrections & education

Media kit, interview requests, and corrections: start at the Press & media page, or email info@7-oh.help.

This site is educational and does not establish a clinician–patient relationship or replace emergency care. Brand home: eusomnia.org.